Skip to Main Content

Good morning, everyone, and welcome to another working week. We hope the weekend respite, if that is the correct word, was somehow relaxing, despite recent events. Now what passes for the usual routine has predictably returned. To cope, yes, we are firing up the trusty coffee kettle and brewing cups of stimulation. The neurons need all the help they can get. Meanwhile, here are a few items of interest as you dig in for a busy day. Keep safe and keep in touch. …

Anthony Fauci, the director of the National Institute for Allergy and Infectious Diseases, was not enthused about a decision by Moderna (MRNA) to issue snippets of early data from the Covid-19 vaccine trial his agency has been conducting without waiting for fuller results, STAT reports. That said, Fauci sees reason for cautious optimism about the Moderna vaccine, and others. The idea of having a vaccine by the end of the year is “aspirational, but it’s certainly doable,” he says.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!